Preventing and controlling bleeding in patients with hemophilia A (factor VIII deficiency), including surgical settings. It may also be used for certain other bleeding conditions. Recombinate is a man-made clotting factor. It is identical to the naturally occurring protein in the body. It works by increasing the amount of clotting factor VIII in the blood, which helps the blood to clot normally.
Recombinate is a drug whose generic name is an antihemophilic factor. Recombinate is a drug that is used both prevents and control bleeding in patients with hemophilia A, a condition also known as factor VIII deficiency. This is inclusive of surgical setting. Recombinate belongs to a drug class that is known as clotting agent.